Susquehanna International Group, LLP Ventyx Biosciences, Inc. Put Options Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
Put Options
12 transactions
Others Institutions Holding VTYX
# of Institutions
118Shares Held
50.6MCall Options Held
151KPut Options Held
45.8K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$56.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$45.6 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.92MShares$37.5 Million1.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.77MShares$36 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$29.6 Million0.4% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $540M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...